Genomic Track

26th November – 16:00 – 17:15 – Session II
Education Track

Implementation of Genomics into Healthcare Systems

Development of major initiatives in genomics and personalised medicine is a global trend with significant investments being committed, for example by the governments of the US and China.

In Europe the most comprehensive initiatives, encompassing clinical implementation, research and enterprise, are being seen in countries such as the UK (100,000 Genomes Project) and France (Médecine Génomique 2025).

There has also been significant long-term investments and strategies relating to genomics, with skills and infrastructure developed in countries such as Estonia, Denmark, Iceland, and Finland; and others leading in the clinical application of genomics, such as the Netherlands.

Here we will provide an overview of developments and best practice mechanisms.

Chair

Ivo Gut

Ivo Gut

Director, Centre nacional d’analisi Genomica (CNAG)

Panel

Robert Johnstone

Robert Johnstone

Board Member, European Patient Forum

Sarah Wordsworth

Sarah Wordsworth

University of Oxford, UK – The Health Economic Evidence for Whole Genome Sequencing

Beata Jagielskai.

Beata Jagielska

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology; Department of Oncological Diagnostic, Cardio-Oncology and Palliative Care, Warsaw, Poland

Steffan Ho

Steffan Ho

Vice President, Head of Translational Oncology, Pfizer

Prediction of treatment outcomes with genomics – Achieving clinical and economic impact for health systems

Christian Bauer

Christian Bauer

Sr Director International Marketing, Genomic Health